Determinants of Vaccine Hesitancy among African American and Black Individuals in the United States of America: A Systematic Literature Review.

Determinants of Vaccine Hesitancy among African American and Black Individuals in the United States of America: A Systematic Literature Review.

Publication date: Mar 07, 2024

Despite the crucial role the COVID-19 vaccine played in curbing the pandemic, a significant portion of Black and African American individuals expressed hesitancy toward being vaccinated. This review aimed to identify the determinants of COVID-19 vaccine hesitancy among Black and African American individuals in the U. S. The literature search was conducted in December 2022 according to the PRISMA criteria focusing on empirical studies. Data extraction methods, critical appraisal, and secondary thematic analysis were conducted on both quantitative and qualitative studies. Sixteen quantitative studies identified the key factors associated with vaccine hesitancy, such as confidence in vaccine effectiveness, safety, and trust in the healthcare system. Fourteen qualitative studies revealed major themes of mistrust, fear, and information needs, including historical mistrust, concerns about the vaccine development process, and contemporary institutional mistrust. The synthesis of quantitative and qualitative findings derived from this review provides a nuanced understanding of the determinants of vaccine hesitancy in Black and African American communities in the U. S., offering a foundation for the development of evidence-based interventions. Mistrust in the healthcare system, fear, and informational gaps on vaccine safety and effectiveness were identified as significant barriers to vaccination, demanding targeted interventions.

Open Access PDF

Concepts Keywords
America African American
Black Black
December COVID-19 vaccine
Pandemic vaccine hesitancy


Type Source Name
disease VO vaccine
disease VO COVID-19 vaccine
disease VO vaccinated
disease VO vaccine effectiveness
disease IDO process
disease VO effectiveness
disease VO vaccination
disease VO USA
disease MESH Emergency
pathway REACTOME Translation
drug DRUGBANK Coenzyme M
disease MESH COVID 19
disease VO population
disease VO organization
drug DRUGBANK Pentaerythritol tetranitrate
disease VO immunization
disease VO effective
disease VO time
disease VO Gap
disease IDO history
drug DRUGBANK Nonoxynol-9
disease IDO intervention
drug DRUGBANK Indoleacetic acid
drug DRUGBANK Methionine
disease VO document
disease VO ineffective
disease IDO quality
disease MESH Syphilis
drug DRUGBANK Water
disease IDO object
disease MESH uncertainty
disease MESH obesity
disease VO Equity
disease MESH educational attainment
disease MESH death
disease MESH infection
disease IDO production
disease VO Coronavirinae
disease VO Coronaviridae
disease VO Betacoronavirus
drug DRUGBANK Sulpiride
disease MESH Lifestyle
disease VO vaccination coverage
disease VO Pal
disease VO coronavirus vaccine

Original Article

(Visited 1 times, 1 visits today)